General Pharmaceuticals
General Pharmaceuticals Limited is a Bangladesh-based, privately held finished-dose pharmaceutical manufacturer founded in 1987 that produces 300+ generic medicines and APIs at a cGMP-certified facility in Gazipur and sells them domestically and to distributors across 25+ countries in Asia, Africa, and the Americas.
- Company typePrivate
- Founded1987
- HeadquartersDhaka, Bangladesh
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What General Pharmaceuticals does
General Pharmaceuticals Limited (GPL) is a Bangladesh-based, privately held finished pharmaceutical formulation manufacturer founded in 1987 and headquartered in Dhaka. The company produces generic medicines and active pharmaceutical ingredients (APIs) across a portfolio of more than 300 products spanning antidiabetics, CNS, anti-Parkinson's, antiallergics, antiulcerants, antibiotics, antifungals, ophthalmics, injectables, statins, anticoagulants, and vitamins. Its marketed specialty products include Tirgen (tirzepatide), Emfogen (empagliflozin), Rosugen (rosuvastatin), Epiclon (clonazepam), SECOCLAV (cefuroxime + clavulanic acid), Voricon (voriconazole), Rabemax (rabeprazole), and Tearfresh (carboxymethylcellulose eye drops).
GPL's manufacturing base is anchored by Unit 2 in Kaliakair, Gazipur — a cGMP-compliant facility that began production in 2011, with a 29,792 sqm site area, a 14,444 sqm building footprint (master-planned by APC, Australia), and dedicated suites for ophthalmic, parenteral, steroidal, non-steroidal, and SVP/LVP (including Amino Acid) production, plus effluent treatment and incineration. The plant is built to UK MHRA, EU-GMP, TGA, ICH, and PIC/S standards, and the company holds ISO 9001:2008 certification (originally ISO 9001:2000 in 2007).
Commercially, GPL distributes domestically via Bangladesh wholesale and retail networks and exports internationally through an International Marketing department established in August 2004. Products reach more than 25 countries across Asia, Africa, and Central/South America. Revenue is generated through one-time product sales to wholesale/distributor customers; pricing is not publicly disclosed. Marketing activities include sponsored participation in regional psychiatric and medical conferences. Operating geographies do not currently include US or EU direct sales despite the plant's regulatory certifications, indicating the next leg of growth is likely tied to deeper penetration of regulated export markets and continued portfolio extension into higher-value therapies.
General Pharmaceuticals firmographics
Firmographics- Name
- General Pharmaceuticals
- Legal name
- General Pharmaceuticals Limited
- Website
- https://generalpharma.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- General Pharmaceuticals Limited is a Bangladesh-based, privately held finished-dose pharmaceutical manufacturer founded in 1987 that produces 300+ generic medicines and APIs at a cGMP-certified facility in Gazipur and sells them domestically and to distributors across 25+ countries in Asia, Africa, and the Americas.
- Ownership category
- akta.pro rank
General Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industries
- Ophthalmology Pharmaceuticals (HLAIAAAL), Small-Molecule API Commercial Manufacturing (HLAGAHAB)
Keywords
Where General Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Dhaka
- HQ country
- Bangladesh
- HQ region
- Asia
Offices2 records
Markets served
General Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Products Manufacturing and Sales: Manufacturing and sale of generic pharmaceutical products including medicines and active pharmaceutical ingredients (APIs) for domestic Bangladesh market and international export markets.
- International Export: Export of pharmaceutical products to regulated and developing countries including North America, South America, Europe, Middle East, Asia, and Africa under international marketing division.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
General Pharmaceuticals product offering
Product offeringCore offering
General Pharmaceuticals Limited manufactures generic finished pharmaceutical formulations and active pharmaceutical ingredients (APIs) at its cGMP-compliant facility in Kaliakair, Gazipur, Bangladesh. The company produces medicines across multiple therapeutic categories including antidiabetics, CNS drugs, anti-Parkinson, antacids, antibiotics, antifungals, anticoagulants, ophthalmics, and sterile injectables for the Bangladesh domestic market and for export to more than 25 countries in regulated and developing markets.
Product overview
General Pharmaceuticals Limited is a Bangladesh-based pharmaceutical manufacturer producing medicines and active pharmaceutical ingredients (APIs) across multiple therapeutic categories. The company operates a cGMP-compliant state-of-the-art manufacturing facility and exports to regulated markets globally. Their product portfolio includes Featured Products (Emfogen, Epiclon, Bost, Rosugen, Tearfresh, SECOCLAV, Voricon, Rabemax, Tirgen), New Products (Blast, Doparkin, Emfolin, Leviceta, DLP, Sugamet XR, Zeroflux, Antixa), and a comprehensive catalog of over 300 pharmaceutical products organized by brand name, generic name, and therapeutic class. The company also offers diagnostic products and health information resources through its Health Corner platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Emfogen
Companies that use General Pharmaceuticals
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
General Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
General Pharmaceuticals partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights4 records
General Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer offering a comparable portfolio of generic formulations and APIs with international exports. Square is the most directly comparable anchor for any Bangladesh-based finished-formulation manufacturer with global ambitions.
- Beximco Pharmaceuticals: Largest Bangladeshi exporter of generics and a peer in API manufacturing, with approved regulatory certifications enabling US/EU market access. Comparable vertical integration from APIs to finished dosage forms targeting the same export geographies.
- Renata Limited: Bangladesh-based pharmaceutical manufacturer producing animal health, human health formulations, and APIs with established exports. Competitor operating in the same domestic market and similar therapeutic categories as GPL.
- Incepta Pharmaceuticals: Major Bangladeshi pharmaceutical manufacturer with a broad generic portfolio and growing exports to emerging markets. Directly comparable on product breadth, domestic vs. export split, and regional reach.
- Eskayef Pharmaceuticals: Bangladesh-based generic pharmaceutical manufacturer with international certification (UK MHRA, EU-GMP) and export activities. Closest peer in therapeutic scope and scale of operations outside the top-three Bangladeshi players.
- ACI Limited (Pharma Division): Diversified Bangladeshi conglomerate with a pharmaceutical division manufacturing branded generics across multiple therapeutic categories. Competes with GPL in domestic sales and adjacent export markets.
- Drug International Limited: Bangladesh-based generic pharmaceutical manufacturer with API capabilities and exports to Asian and African markets. Closely comparable mid-tier Bangladesh peer in manufacturing footprint and product mix.
Broad incumbents
- Aurobindo Pharma: India-headquartered global generic manufacturer with extensive US FDA, UK MHRA, and EU-GMP approvals across API and finished dosage manufacturing. Represents the scaled competitor GPL must position against in regulated export markets.
- Dr. Reddy's Laboratories: India-based vertically integrated global generics and API manufacturer exporting to regulated markets with a wide therapeutic portfolio. Comparable in scope and parent-product type, but materially larger and more diversified.
- Cipla Limited: One of India's largest pharmaceutical manufacturers with global presence across generics, APIs, and specialty dosage forms. Comparable product breadth to GPL's portfolio but at meaningfully larger scale and geographic footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
General Pharmaceuticals social profiles
Digital presenceGeneral Pharmaceuticals compliance and trust
Trust signalCompliance3 records
General Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
General Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
General Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
General Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about General Pharmaceuticals
What does General Pharmaceuticals do?
General Pharmaceuticals Limited manufactures generic finished pharmaceutical formulations and active pharmaceutical ingredients (APIs) at its cGMP-compliant facility in Kaliakair, Gazipur, Bangladesh. The company produces medicines across multiple therapeutic categories including antidiabetics, CNS drugs, anti-Parkinson, antacids, antibiotics, antifungals, anticoagulants, ophthalmics, and sterile injectables for the Bangladesh domestic market and for export to more than 25 countries in regulated and developing markets.
Is General Pharmaceuticals a public or private company?
General Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was General Pharmaceuticals founded?
General Pharmaceuticals was founded in 1987. It employs 1,001 to 5,000 people.
Where is General Pharmaceuticals based?
General Pharmaceuticals is headquartered in Dhaka, Bangladesh, in the Asia region.
How does General Pharmaceuticals make money?
Two revenue lines are on record. Pharmaceutical Products Manufacturing and Sales are the primary driver. The others are international Export.
Who are General Pharmaceuticals's main competitors?
Direct peers on record are Square Pharmaceuticals, Beximco Pharmaceuticals, Renata Limited, Incepta Pharmaceuticals, Eskayef Pharmaceuticals, ACI Limited (Pharma Division) and Drug International Limited. Broad incumbents are Aurobindo Pharma, Dr. Reddy's Laboratories and Cipla Limited.
Does General Pharmaceuticals have an API?
No public API is recorded for General Pharmaceuticals.
What industry is General Pharmaceuticals in?
General Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.